Pfizer (PFE) earnings Q2 2022


Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in boxes, at Misericordia hospital in Grosseto, Italy, February 8, 2022.

Jennifer Lorenzini | Reuters

Pfizer’s second-quarter revenue and profit beat Wall Street expectations, driven by sales of its Covid-19 vaccine and its antiviral treatment Paxlovid.

Pfizer booked $27.7 billion in revenue, a 47% increase over the same period last year and its largest quarterly sales on record. The pharmaceutical company reported $9.9 billion in net income, a 78% increase over the second quarter of 2021.

Here’s how the company performed compared with what Wall Street expected for the second quarter, based on analysts’ average estimates compiled…

Source cnbc.com

0 0 votes
Article Rating

Here’s what a possible recession could mean for American consumers

Previous article

The economy may look like it’s in recession, but we still don’t know for sure

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings